1st Circ. Considers Rejecting $24M Zoladex Deal
In a dispute over whether the agreement was unfair, a federal appeals court is considering whether to reject a $24 million settlement in a suit brought by consumers against AstraZeneca Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article